APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery Device

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmic Drug Delivery Device Industry Growth and Trends Forecast to 2032

Report ID 17442735034 July 2026117 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery Device Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery Device Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery Device Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery Device Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Drug Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Drug Delivery Device include West Pharmaceutical Services, Inc., Terumo Corporation, Silgan Holdings Inc., Re-Vana Therapeutics, Owen Mumford, Ocumedic, Inc., Ocular Therapeutix, Nipro Corporation and Nemera, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic Drug Delivery Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic Drug Delivery Device market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic Drug Delivery Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic Drug Delivery Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmic Drug Delivery Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic Drug Delivery Device Market by Company

West Pharmaceutical Services, Inc.

Terumo Corporation

Silgan Holdings Inc.

Re-Vana Therapeutics

Owen Mumford

Ocumedic, Inc.

Ocular Therapeutix

Nipro Corporation

Nemera

Mati Therapeutics, Inc.,

Kedalion Therapeutics

Gerresheimer

Gaplast GmbH

EyePoint Pharmaceuticals, Inc.

Biocorp Production

Becton Dickinson & Company

Bausch Health

AptarGroup

Aero Pump GmbH

Ophthalmic Drug Delivery Device Segment by Type

Multidose Eyedroppers

Add-On Devices

Squeeze Dispenser

Mist Sprayers

Contact Lenses

Pre-Filled Syringes

Others

Ophthalmic Drug Delivery Device Segment by Application

Clinics

Hospitals

Homecare

Others

Ophthalmic Drug Delivery Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Drug Delivery Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmic Drug Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Multidose Eyedroppers Table 2. Major Company of Add-On Devices Table 3. Major Company of Squeeze Dispenser Table 4. Major Company of Mist Sprayers Table 5. Major Company of Contact Lenses Table 6. Major Company of Pre-Filled Syringes Table 7. Major Company of Others Table 8. Global Ophthalmic Drug Delivery Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 10. Global Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type (2021-2026) Table 11. Global Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (US$ Million) Table 12. Global Ophthalmic Drug Delivery Device Sales Market Share in Value by Type (2021-2026) Table 13. Global Ophthalmic Drug Delivery Device Price by Type (2021-2026) & (USD/unit) Table 14. Global Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 15. Global Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type (2027-2032) Table 16. Global Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (US$ Million) Table 17. Global Ophthalmic Drug Delivery Device Sales Market Share in Value by Type (2027-2032) Table 18. Global Ophthalmic Drug Delivery Device Price by Type (2027-2032) & (USD/unit) Table 19. North America Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 20. North America Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 22. Europe Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 24. Asia-Pacific Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 26. Latin America Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 28. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (US$ Million) Table 29. Ophthalmic Drug Delivery Device Industry Trends Table 30. Ophthalmic Drug Delivery Device Industry Drivers Table 31. Ophthalmic Drug Delivery Device Industry Opportunities and Challenges Table 32. Ophthalmic Drug Delivery Device Industry Restraints Table 33. Global Ophthalmic Drug Delivery Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Ophthalmic Drug Delivery Device Revenue Market Share by Company (2021-2026) Table 35. Global Ophthalmic Drug Delivery Device Sales by Company (2021-2026) & (k units) Table 36. Global Ophthalmic Drug Delivery Device Sales Share by Company (2021-2026) Table 37. Global Ophthalmic Drug Delivery Device Market Price by Company (2021-2026) & (USD/unit) Table 38. Global Ophthalmic Drug Delivery Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Ophthalmic Drug Delivery Device Major Company Production Sites and Headquarters Table 40. Global Ophthalmic Drug Delivery Device Company, Product Type & Application Table 41. Global Ophthalmic Drug Delivery Device Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Ophthalmic Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Ophthalmic Drug Delivery Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Ophthalmic Drug Delivery Device Sales by Region (2021-2026) & (k units) Table 46. Global Ophthalmic Drug Delivery Device Sales Market Share in Volume by Region (2021-2026) Table 47. Global Ophthalmic Drug Delivery Device Sales by Region (2021-2026) & (US$ Million) Table 48. Global Ophthalmic Drug Delivery Device Sales Market Share in Value by Region (2021-2026) Table 49. Global Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 50. Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032) & (k units) Table 51. Global Ophthalmic Drug Delivery Device Sales Market Share in Volume by Region (2027-2032) Table 52. Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032) & (US$ Million) Table 53. Global Ophthalmic Drug Delivery Device Sales Market Share in Value by Region (2027-2032) Table 54. Global Ophthalmic Drug Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 55. Global Ophthalmic Drug Delivery Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 57. Global Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application (2021-2026) Table 58. Global Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (US$ Million) Table 59. Global Ophthalmic Drug Delivery Device Sales Market Share in Value by Application (2021-2026) Table 60. Global Ophthalmic Drug Delivery Device Price by Application (2021-2026) & (USD/unit) Table 61. Global Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 62. Global Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application (2027-2032) Table 63. Global Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (US$ Million) Table 64. Global Ophthalmic Drug Delivery Device Sales Market Share in Value by Application (2027-2032) Table 65. Global Ophthalmic Drug Delivery Device Price by Application (2027-2032) & (USD/unit) Table 66. North America Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 67. North America Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 69. Europe Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 71. Asia-Pacific Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 73. Latin America Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 75. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (US$ Million) Table 76. West Pharmaceutical Services, Inc. Company Information Table 77. West Pharmaceutical Services, Inc. Business Overview Table 78. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 80. West Pharmaceutical Services, Inc. Recent Development Table 81. Terumo Corporation Company Information Table 82. Terumo Corporation Business Overview Table 83. Terumo Corporation Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio Table 85. Terumo Corporation Recent Development Table 86. Silgan Holdings Inc. Company Information Table 87. Silgan Holdings Inc. Business Overview Table 88. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 90. Silgan Holdings Inc. Recent Development Table 91. Re-Vana Therapeutics Company Information Table 92. Re-Vana Therapeutics Business Overview Table 93. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio Table 95. Re-Vana Therapeutics Recent Development Table 96. Owen Mumford Company Information Table 97. Owen Mumford Business Overview Table 98. Owen Mumford Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio Table 100. Owen Mumford Recent Development Table 101. Ocumedic, Inc. Company Information Table 102. Ocumedic, Inc. Business Overview Table 103. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 105. Ocumedic, Inc. Recent Development Table 106. Ocular Therapeutix Company Information Table 107. Ocular Therapeutix Business Overview Table 108. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio Table 110. Ocular Therapeutix Recent Development Table 111. Nipro Corporation Company Information Table 112. Nipro Corporation Business Overview Table 113. Nipro Corporation Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio Table 115. Nipro Corporation Recent Development Table 116. Nemera Company Information Table 117. Nemera Business Overview Table 118. Nemera Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Nemera Ophthalmic Drug Delivery Device Product Portfolio Table 120. Nemera Recent Development Table 121. Mati Therapeutics, Inc., Company Information Table 122. Mati Therapeutics, Inc., Business Overview Table 123. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio Table 125. Mati Therapeutics, Inc., Recent Development Table 126. Kedalion Therapeutics Company Information Table 127. Kedalion Therapeutics Business Overview Table 128. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio Table 130. Kedalion Therapeutics Recent Development Table 131. Gerresheimer Company Information Table 132. Gerresheimer Business Overview Table 133. Gerresheimer Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio Table 135. Gerresheimer Recent Development Table 136. Gaplast GmbH Company Information Table 137. Gaplast GmbH Business Overview Table 138. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio Table 140. Gaplast GmbH Recent Development Table 141. EyePoint Pharmaceuticals, Inc. Company Information Table 142. EyePoint Pharmaceuticals, Inc. Business Overview Table 143. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 145. EyePoint Pharmaceuticals, Inc. Recent Development Table 146. Biocorp Production Company Information Table 147. Biocorp Production Business Overview Table 148. Biocorp Production Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio Table 150. Biocorp Production Recent Development Table 151. Becton Dickinson & Company Company Information Table 152. Becton Dickinson & Company Business Overview Table 153. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio Table 155. Becton Dickinson & Company Recent Development Table 156. Bausch Health Company Information Table 157. Bausch Health Business Overview Table 158. Bausch Health Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. Bausch Health Ophthalmic Drug Delivery Device Product Portfolio Table 160. Bausch Health Recent Development Table 161. AptarGroup Company Information Table 162. AptarGroup Business Overview Table 163. AptarGroup Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. AptarGroup Ophthalmic Drug Delivery Device Product Portfolio Table 165. AptarGroup Recent Development Table 166. Aero Pump GmbH Company Information Table 167. Aero Pump GmbH Business Overview Table 168. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio Table 170. Aero Pump GmbH Recent Development Table 171. North America Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. North America Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 173. North America Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2026) Table 174. North America Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032) & (k units) Table 175. North America Ophthalmic Drug Delivery Device Sales Market Share Forecast by Country (2027-2032) Table 176. North America Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Ophthalmic Drug Delivery Device Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Ophthalmic Drug Delivery Device Market Share by Country (2021-2026) Table 179. North America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Ophthalmic Drug Delivery Device Market Share Forecast by Country (2027-2032) Table 181. Europe Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Europe Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 183. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2026) Table 184. Europe Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032) & (k units) Table 185. Europe Ophthalmic Drug Delivery Device Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Ophthalmic Drug Delivery Device Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Ophthalmic Drug Delivery Device Market Share by Country (2021-2026) Table 189. Europe Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Ophthalmic Drug Delivery Device Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 193. Asia-Pacific Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032) & (k units) Table 195. Asia-Pacific Ophthalmic Drug Delivery Device Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Ophthalmic Drug Delivery Device Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Ophthalmic Drug Delivery Device Market Share by Country (2021-2026) Table 199. Asia-Pacific Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Ophthalmic Drug Delivery Device Market Share Forecast by Country (2027-2032) Table 201. Latin America Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 202. Latin America Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 203. Latin America Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2026) Table 204. Latin America Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032) & (k units) Table 205. Latin America Ophthalmic Drug Delivery Device Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Ophthalmic Drug Delivery Device Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Ophthalmic Drug Delivery Device Market Share by Country (2021-2026) Table 209. Latin America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Ophthalmic Drug Delivery Device Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 213. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032) & (k units) Table 215. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Ophthalmic Drug Delivery Device Market Share by Country (2021-2026) Table 219. Middle East and Africa Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Ophthalmic Drug Delivery Device Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Ophthalmic Drug Delivery Device Distributors List Table 224. Ophthalmic Drug Delivery Device Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery Device Image Figure 2. Global Ophthalmic Drug Delivery Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Drug Delivery Device Sales (2021-2032) & (k units) Figure 5. Multidose Eyedroppers Image Figure 6. Global Multidose Eyedroppers Sales YoY Growth (2021-2032) & (k units) Figure 7. Add-On Devices Image Figure 8. Global Add-On Devices Sales YoY Growth (2021-2032) & (k units) Figure 9. Squeeze Dispenser Image Figure 10. Global Squeeze Dispenser Sales YoY Growth (2021-2032) & (k units) Figure 11. Mist Sprayers Image Figure 12. Global Mist Sprayers Sales YoY Growth (2021-2032) & (k units) Figure 13. Contact Lenses Image Figure 14. Global Contact Lenses Sales YoY Growth (2021-2032) & (k units) Figure 15. Pre-Filled Syringes Image Figure 16. Global Pre-Filled Syringes Sales YoY Growth (2021-2032) & (k units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 19. Global Ophthalmic Drug Delivery Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Ophthalmic Drug Delivery Device Market Share by Type 2025 VS 2032 Figure 21. North America Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type in 2025 Figure 22. North America Ophthalmic Drug Delivery Device Sales Market Share in Value by Type in 2025 Figure 23. Europe Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type in 2025 Figure 24. Europe Ophthalmic Drug Delivery Device Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Ophthalmic Drug Delivery Device Sales Market Share in Value by Type in 2025 Figure 27. Latin America Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Ophthalmic Drug Delivery Device Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Ophthalmic Drug Delivery Device Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Clinics Image Figure 34. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 35. Hospitals Image Figure 36. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 37. Homecare Image Figure 38. Global Homecare Sales YoY Growth (2021-2032) & (k units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 41. Global Ophthalmic Drug Delivery Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Ophthalmic Drug Delivery Device Market Share by Application 2025 VS 2032 Figure 43. North America Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application in 2025 Figure 44. North America Ophthalmic Drug Delivery Device Sales Market Share in Value by Application in 2025 Figure 45. Europe Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application in 2025 Figure 46. Europe Ophthalmic Drug Delivery Device Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Ophthalmic Drug Delivery Device Sales Market Share in Value by Application in 2025 Figure 49. Latin America Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Ophthalmic Drug Delivery Device Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share in Value by Application in 2025 Figure 53. North America Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America Ophthalmic Drug Delivery Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Ophthalmic Drug Delivery Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe Ophthalmic Drug Delivery Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Ophthalmic Drug Delivery Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific Ophthalmic Drug Delivery Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Ophthalmic Drug Delivery Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America Ophthalmic Drug Delivery Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Ophthalmic Drug Delivery Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa Ophthalmic Drug Delivery Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Ophthalmic Drug Delivery Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Ophthalmic Drug Delivery Device Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Ophthalmic Drug Delivery Device Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Multidose Eyedroppers
  • Add-On Devices
  • Squeeze Dispenser
  • Mist Sprayers
  • Contact Lenses
  • Pre-Filled Syringes
  • Others
Applications
  • Clinics
  • Hospitals
  • Homecare
  • Others
Companies covered
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Silgan Holdings Inc.
  • Re-Vana Therapeutics
  • Owen Mumford
  • Ocumedic, Inc.
  • Ocular Therapeutix
  • Nipro Corporation
  • Nemera
  • Mati Therapeutics, Inc.,
  • Kedalion Therapeutics
  • Gerresheimer
  • Gaplast GmbH
  • EyePoint Pharmaceuticals, Inc.
  • Biocorp Production
  • Becton Dickinson & Company
  • Bausch Health
  • AptarGroup
  • Aero Pump GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Drug Delivery Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmic Drug Delivery Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmic Drug Delivery Device Market by Type
  6. 1.3.1 Multidose Eyedroppers
  7. 1.3.2 Add-On Devices
  8. 1.3.3 Squeeze Dispenser
  9. 1.3.4 Mist Sprayers
  10. 1.3.5 Contact Lenses
  11. 1.3.6 Pre-Filled Syringes
  12. 1.3.7 Others
  13. 1.4 Global Ophthalmic Drug Delivery Device Market Size by Type
  14. 1.4.1 Global Ophthalmic Drug Delivery Device Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Ophthalmic Drug Delivery Device Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Ophthalmic Drug Delivery Device Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Ophthalmic Drug Delivery Device Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Ophthalmic Drug Delivery Device Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Ophthalmic Drug Delivery Device Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Ophthalmic Drug Delivery Device Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Ophthalmic Drug Delivery Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery Device Industry Trends
  2. 2.2 Ophthalmic Drug Delivery Device Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery Device Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmic Drug Delivery Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmic Drug Delivery Device Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmic Drug Delivery Device Price (2021-2026)
  4. 3.4 Global Ophthalmic Drug Delivery Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Drug Delivery Device Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmic Drug Delivery Device Company, Product Type & Application
  7. 3.7 Global Ophthalmic Drug Delivery Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Drug Delivery Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Drug Delivery Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Drug Delivery Device Tier 1, Tier 2, and Tier 3
4 Ophthalmic Drug Delivery Device Regional Status and Outlook
  1. 4.1 Global Ophthalmic Drug Delivery Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmic Drug Delivery Device Historic Market Size by Region
  3. 4.2.1 Global Ophthalmic Drug Delivery Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmic Drug Delivery Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmic Drug Delivery Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmic Drug Delivery Device Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmic Drug Delivery Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmic Drug Delivery Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmic Drug Delivery Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmic Drug Delivery Device by Application
  1. 5.1 Ophthalmic Drug Delivery Device Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Homecare
  5. 5.1.4 Others
  6. 5.2 Global Ophthalmic Drug Delivery Device Market Size by Application
  7. 5.2.1 Global Ophthalmic Drug Delivery Device Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ophthalmic Drug Delivery Device Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ophthalmic Drug Delivery Device Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ophthalmic Drug Delivery Device Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ophthalmic Drug Delivery Device Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ophthalmic Drug Delivery Device Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ophthalmic Drug Delivery Device Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ophthalmic Drug Delivery Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 West Pharmaceutical Services, Inc.
  2. 6.1.1 West Pharmaceutical Services, Inc. Company Information
  3. 6.1.2 West Pharmaceutical Services, Inc. Business Overview
  4. 6.1.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  6. 6.1.5 West Pharmaceutical Services, Inc. Recent Developments
  7. 6.2 Terumo Corporation
  8. 6.2.1 Terumo Corporation Company Information
  9. 6.2.2 Terumo Corporation Business Overview
  10. 6.2.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
  12. 6.2.5 Terumo Corporation Recent Developments
  13. 6.3 Silgan Holdings Inc.
  14. 6.3.1 Silgan Holdings Inc. Company Information
  15. 6.3.2 Silgan Holdings Inc. Business Overview
  16. 6.3.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
  18. 6.3.5 Silgan Holdings Inc. Recent Developments
  19. 6.4 Re-Vana Therapeutics
  20. 6.4.1 Re-Vana Therapeutics Company Information
  21. 6.4.2 Re-Vana Therapeutics Business Overview
  22. 6.4.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
  24. 6.4.5 Re-Vana Therapeutics Recent Developments
  25. 6.5 Owen Mumford
  26. 6.5.1 Owen Mumford Company Information
  27. 6.5.2 Owen Mumford Business Overview
  28. 6.5.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
  30. 6.5.5 Owen Mumford Recent Developments
  31. 6.6 Ocumedic, Inc.
  32. 6.6.1 Ocumedic, Inc. Company Information
  33. 6.6.2 Ocumedic, Inc. Business Overview
  34. 6.6.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  36. 6.6.5 Ocumedic, Inc. Recent Developments
  37. 6.7 Ocular Therapeutix
  38. 6.7.1 Ocular Therapeutix Company Information
  39. 6.7.2 Ocular Therapeutix Business Overview
  40. 6.7.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
  42. 6.7.5 Ocular Therapeutix Recent Developments
  43. 6.8 Nipro Corporation
  44. 6.8.1 Nipro Corporation Company Information
  45. 6.8.2 Nipro Corporation Business Overview
  46. 6.8.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
  48. 6.8.5 Nipro Corporation Recent Developments
  49. 6.9 Nemera
  50. 6.9.1 Nemera Company Information
  51. 6.9.2 Nemera Business Overview
  52. 6.9.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Nemera Ophthalmic Drug Delivery Device Product Portfolio
  54. 6.9.5 Nemera Recent Developments
  55. 6.10 Mati Therapeutics, Inc.,
  56. 6.10.1 Mati Therapeutics, Inc., Company Information
  57. 6.10.2 Mati Therapeutics, Inc., Business Overview
  58. 6.10.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
  60. 6.10.5 Mati Therapeutics, Inc., Recent Developments
  61. 6.11 Kedalion Therapeutics
  62. 6.11.1 Kedalion Therapeutics Company Information
  63. 6.11.2 Kedalion Therapeutics Business Overview
  64. 6.11.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
  66. 6.11.5 Kedalion Therapeutics Recent Developments
  67. 6.12 Gerresheimer
  68. 6.12.1 Gerresheimer Company Information
  69. 6.12.2 Gerresheimer Business Overview
  70. 6.12.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
  72. 6.12.5 Gerresheimer Recent Developments
  73. 6.13 Gaplast GmbH
  74. 6.13.1 Gaplast GmbH Company Information
  75. 6.13.2 Gaplast GmbH Business Overview
  76. 6.13.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
  78. 6.13.5 Gaplast GmbH Recent Developments
  79. 6.14 EyePoint Pharmaceuticals, Inc.
  80. 6.14.1 EyePoint Pharmaceuticals, Inc. Company Information
  81. 6.14.2 EyePoint Pharmaceuticals, Inc. Business Overview
  82. 6.14.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  84. 6.14.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  85. 6.15 Biocorp Production
  86. 6.15.1 Biocorp Production Company Information
  87. 6.15.2 Biocorp Production Business Overview
  88. 6.15.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
  90. 6.15.5 Biocorp Production Recent Developments
  91. 6.16 Becton Dickinson & Company
  92. 6.16.1 Becton Dickinson & Company Company Information
  93. 6.16.2 Becton Dickinson & Company Business Overview
  94. 6.16.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
  96. 6.16.5 Becton Dickinson & Company Recent Developments
  97. 6.17 Bausch Health
  98. 6.17.1 Bausch Health Company Information
  99. 6.17.2 Bausch Health Business Overview
  100. 6.17.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
  102. 6.17.5 Bausch Health Recent Developments
  103. 6.18 AptarGroup
  104. 6.18.1 AptarGroup Company Information
  105. 6.18.2 AptarGroup Business Overview
  106. 6.18.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
  108. 6.18.5 AptarGroup Recent Developments
  109. 6.19 Aero Pump GmbH
  110. 6.19.1 Aero Pump GmbH Company Information
  111. 6.19.2 Aero Pump GmbH Business Overview
  112. 6.19.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
  114. 6.19.5 Aero Pump GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmic Drug Delivery Device Sales by Country
  2. 7.1.1 North America Ophthalmic Drug Delivery Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmic Drug Delivery Device Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmic Drug Delivery Device Market Size by Country
  6. 7.2.1 North America Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmic Drug Delivery Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmic Drug Delivery Device Sales by Country
  2. 8.1.1 Europe Ophthalmic Drug Delivery Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmic Drug Delivery Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmic Drug Delivery Device Market Size by Country
  6. 8.2.1 Europe Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmic Drug Delivery Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmic Drug Delivery Device Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmic Drug Delivery Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmic Drug Delivery Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmic Drug Delivery Device Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmic Drug Delivery Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmic Drug Delivery Device Sales by Country
  2. 10.1.1 South America Ophthalmic Drug Delivery Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmic Drug Delivery Device Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmic Drug Delivery Device Market Size by Country
  6. 10.2.1 South America Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmic Drug Delivery Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmic Drug Delivery Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmic Drug Delivery Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmic Drug Delivery Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmic Drug Delivery Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmic Drug Delivery Device Value Chain Analysis
  2. 12.1.1 Ophthalmic Drug Delivery Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmic Drug Delivery Device Production Mode & Process
  7. 12.2 Ophthalmic Drug Delivery Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmic Drug Delivery Device Distributors
  10. 12.2.3 Ophthalmic Drug Delivery Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst